Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Addressing Help-Seeking Barriers in Developing an Intensive Treatment for Veterans With Panic Disorder

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00628979
Recruitment Status : Completed
First Posted : March 5, 2008
Last Update Posted : July 3, 2009
Sponsor:
Information provided by:
VA Office of Research and Development

Brief Summary:
The purpose of this study is to understand some of the reasons why recently deployed veterans decline psychosocial treatment options for panic disorder and to test a brief weekend treatment for panic attacks.

Condition or disease Intervention/treatment Phase
Panic Disorder Behavioral: CBT Not Applicable

Detailed Description:
The population of interest for this program includes men and women returning from deployment in Iraq or Afghanistan who are seen in the TRP at the MEDVAMC. The study consists of two parts: PART 1 involves a qualitative investigation of treatment-seeking barriers specific to persons who refuse standard treatments and PART 2 is a pilot intervention to treat panic symptoms in service members who have co-existing PTSD symptoms. PART 1 will include approximately 15 individuals who will be interviewed by a member of the study staff. Patients will be interviewed individually following a semi-structured questionnaire designed to help identify treatment-seeking barriers. PART 2 will include 8 individuals who will be enrolled in an open-trial of a two-day intensive cognitive-behavioral treatment for panic disorder, which will occur over the weekend. No participants will be assigned to a control condition. All activities related to this project including the interviews and intervention will be delivered in either the TRP at the MEDVAMC or at the Houston Center for Quality of Care and Utilization Studies (HCQCUS), a nearby facility.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 23 participants
Allocation: N/A
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Addressing Help-Seeking Barriers in Developing an Intensive Treatment for Veterans With Panic Disorder
Study Start Date : March 2008
Actual Primary Completion Date : March 2008
Actual Study Completion Date : July 2009

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Panic Disorder

Arm Intervention/treatment
1
CBT
Behavioral: CBT
cognitive- behavioral treatment for panic disorder.




Primary Outcome Measures :
  1. Qualitative data regarding treatment seeking barriers [ Time Frame: 6 months ]

Secondary Outcome Measures :
  1. Panic attack frequency and severity; treatment acceptability [ Time Frame: 6 months ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 74 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  1. Veterans;
  2. age 18-74;
  3. current diagnosis of panic disorder;
  4. PTSD symptoms that either meet full diagnostic criteria from the Diagnostic and Statistical Manual-Fourth Edition (DSM-IV) or are at a sub-clinical level. Sub-clinical PTSD is defined as patients who meet either PTSD criteria B and C or B and D, but fail to meet all three;
  5. panic disorder and PTSD present for at least 1 month;
  6. PART 1 only: patients who are clinically eligible to participate in the study and refuse standard psychosocial treatments (e.g., 12 weeks of cognitive behavioral therapy) for panic disorder.

Exclusion Criteria:

  1. Current substance dependence;
  2. diagnosed with bipolar disorder or psychosis;
  3. current suicidal/homicidal ideation and intent;
  4. severe depression (precluding participation in a research study);
  5. panic attacks related only to a diagnosis of a specific phobia;
  6. medical conditions mimicing anxiety (e.g., mitral valve prolapse);
  7. PART 1 only: patients who are clinically eligible for the study and are willing to engage in a minimum of 12 weeks of psychosocial treatment for panic disorder.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00628979


Locations
Layout table for location information
United States, Texas
Michael E. DeBakey VA Medical Center (152)
Houston, Texas, United States, 77030
Sponsors and Collaborators
US Department of Veterans Affairs
Investigators
Layout table for investigator information
Principal Investigator: Ellen Teng, PhD Michael E. DeBakey VA Medical Center (152)
Layout table for additonal information
Responsible Party: Teng, Ellen - Principal Investigator, Department of Veterans Affairs
ClinicalTrials.gov Identifier: NCT00628979    
Other Study ID Numbers: MIRECC004
First Posted: March 5, 2008    Key Record Dates
Last Update Posted: July 3, 2009
Last Verified: July 2009
Additional relevant MeSH terms:
Layout table for MeSH terms
Panic Disorder
Anxiety Disorders
Mental Disorders